par Zardavas, Dimitros ;Bozovic, Ivana ;de Azambuja, Evandro
Référence Current opinion in oncology, 24, 6, page (612-622)
Publication Publié, 2012-11
Référence Current opinion in oncology, 24, 6, page (612-622)
Publication Publié, 2012-11
Article révisé par les pairs
Titre: |
|
Auteur: | Zardavas, Dimitros; Bozovic, Ivana; de Azambuja, Evandro |
Informations sur la publication: | Current opinion in oncology, 24, 6, page (612-622) |
Statut de publication: | Publié, 2012-11 |
Sujet CREF: | Cancérologie |
Mots-clés: | breast cancer |
dual antihuman epidermal growth factor receptor 2 blockade | |
human epidermal growth factor receptor 2 | |
MeSH keywords: | Antibodies, Monoclonal, Humanized -- administration & dosage |
Antineoplastic Combined Chemotherapy Protocols -- pharmacology -- therapeutic use | |
Breast Neoplasms -- drug therapy -- metabolism | |
Clinical Trials as Topic | |
Female | |
Humans | |
Molecular Targeted Therapy | |
Neoplasms, Hormone-Dependent -- drug therapy -- metabolism | |
Quinazolines -- administration & dosage | |
Quinolines -- administration & dosage | |
Receptor, erbB-2 -- antagonists & inhibitors -- metabolism | |
Signal Transduction | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
Review | |
SCOPUS: re.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:1040-8746 |
info:doi/10.1097/CCO.0b013e328358a29a | |
info:scp/84868205001 | |
info:pmid/23014186 |